The personal and economic impact of headache disorders

The personal and economic impact of headache disorders 

Headache disorders cause enormous suffering for huge numbers of people. In this blog, we’ve explored many times how migraine, tension-type headache (or just “tension headache”), and medication-overuse headache can disrupt everyday life (for example, in this article).

But headaches also come at a huge economic cost. Headache disorders have an impact reaching far beyond the individual, affecting society as a whole.

Neurological disorders are on the rise everywhere

The World Health Organization (WHO) ranks headache disorders among the leading causes of disability worldwide, with a profound impact on those affected. In fact, the latest Global Burden of Disease Study found that neurological disorders now represent the largest overall disease burden worldwide. Neurological disorders place an even greater burden on global health than cardiovascular disorders, which are often considered to be the world's leading health challenge.

Neurological conditions are not just a problem in Europe or other ‘Western’ countries. The WHO study estimates that about one in three people worldwide lives with a neurological disorder. That’s around three billion people across the globe, far more than previously thought. Worrying trends are evident, too: the findings show that, over the past 31 years, disability, illness, and premature death caused by neurological disorders have increased by 18% worldwide.

Headache disorders: a global health problem

Of the 37 neurological disorders included in the study, tension-type headache is the most common, affecting around two billion people. Migraine comes next, affecting about one billion. The researchers believe several factors are driving this increase, including population growth, ageing populations, and greater exposure to environmental and lifestyle-related risks.

Germany is no exception

Headache disorders also top the list of healthcare issues in Germany. Studies from the Kiel Pain Clinic estimate that around 54 million people are affected. The two most common headache disorders are tension-type headache (38.3%) and migraine (27.5%). Together, they account for about 92% of all headaches. Overall, around 71% of the German population experience headaches at some point in their lives. Every day, an estimated 900,000 people have a migraine attack. Around 100,000 of them are unable to work because of their symptoms.

Professor Hartmut Göbel, a neurologist and founder of the Kiel Pain Clinic, points out that both the frequency and the severity of headaches and migraine attacks have increased markedly in recent years. He believes our modern lifestyle may be part of the reason. Modern life places our nervous system under constant and growing pressure, and it is increasingly being pushed to its limits. Even more concerning is that, according to Göbel, although more people need treatment, only around 20% of those affected in Europe actually receive medical care. In other words, just one in five people with a headache disorder sees a doctor. Instead, many turn to unconventional treatments that are not evidence-based, says Göbel.

What headaches cost: figures from one hospital

This immense impact of headache disorders on society also comes at a huge economic cost, as numerous studies have shown. A study carried out at a large Swiss university hospital highlights just how expensive headaches can be in a healthcare setting. More than 60% of hospital employees reported having headaches during the research period. Because of sick leave and reduced productivity while at work, each affected employee lost the equivalent of around 10 working days per year. Altogether, the hospital estimated the financial impact at almost €10 million annually – more than 3% of its total personnel costs.

A heavy human and economic toll

When people with headache disorders lack proper information about prevention and do not receive an accurate diagnosis and appropriate treatment, many end up trying to manage their symptoms on their own. Every day, an estimated three million people in Germany resort to self-medication for their headaches. Besides increasing the risk of medication-overuse headache (read more in this article), the widespread practice of self-treatment also comes with a hefty price tag. Medication used to treat migraine – both prescription and over-the-counter products – is estimated to cost between €150 million and €500 million every year.

Headaches are also one of the leading causes of short-term sick leave. In Germany alone, the working days lost each year because of migraine add up to the equivalent of 185,000 full-time jobs. The resulting economic cost is estimated at €3.5 billion. On top of that, people who go to work despite having a headache often cannot perform at their usual level, adding another estimated €3 billion in lost productivity to the bill.

Overall, headache disorders cost Germany around €27 billion every year. Across the European Union, the annual cost is estimated at about €170 billion. These figures do not include unpaid work – such as looking after children, caring for family members, or running a household – that cannot be done because of headaches. Headache disorders are also linked to a higher risk of other health conditions. For example, people with migraine are up to seven times more likely to develop depression or anxiety disorders. They also have about twice the risk of cardiovascular disease, including heart attacks (read more about headache-related comorbidities in this article).

The invisible headache epidemic

Despite being so common and so disabling, headache disorders are still significantly undertreated. Fewer than 20% of affected people receive medical care, and fewer than one in ten are offered appropriate preventive treatment. As a result, both the personal and economic burden continues to grow. When untreated or treated incorrectly, headaches can become chronic. What may begin as occasional attacks can gradually develop into chronic, ongoing pain. Chronic headaches can have a profound impact on quality of life. Everyday activities become difficult and social isolation is a common result.

Because headaches are an invisible condition, they are still often dismissed as a minor inconvenience that people simply have to live with. The pain a person with migraine experiences during repeated, severe attacks is difficult for others to fully understand. The wider impact on a person’s career, family life, leisure activities, and – ultimately – on society as a whole also goes unseen.

So, what can be done about this silent epidemic? Our knowledge of what causes headache disorders – and of the burden they place on individuals, society, and the economy – is constantly expanding. Research has also made impressive progress in finding better ways to prevent and treat the various headache types. Now it's time to put this knowledge into practice. Headache disorders need to become a much higher priority in healthcare.

Prevention and treatment go hand in hand

To reduce personal suffering and limit the wider social and economic impact, access to proper medical care is essential. Furthermore, to prevent avoidable headaches, effective, long-term education and awareness initiatives are just as important. Because we know that part of the headache burden is linked to modern lifestyles, we also know where to intervene. By reducing everyday factors that can trigger or worsen headaches, many attacks can be prevented. A growing body of research shows that behavioural approaches can significantly reduce both the frequency and severity of migraine and tension-type headaches – and, in turn, help prevent medication-overuse headache.

To achieve this, people need to understand their own type of headache disorder and know how to make sustainable lifestyle changes that can help manage it. People who understand their headaches often have far more control over them than they realise. Better education and support can reduce not only individual suffering but also the considerable economic burden that headache disorders place on society.

Published: July 2026